Published in Women's Health Weekly, October 24th, 2002
B. McElhinney and colleagues, Queens University Belfast, North Ireland, collected serum from five patients who underwent controlled ovarian hyperstimulation as part of an in vitro fertilization cycle and who developed severe OHSS, and from five control subjects.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.